Swedish Orphan Fair Value
SO
The fair market value of SOBI.ST stock is 130.6 SEK. Relative to the market price of 323.8 SEK Swedish Orphan Biovitrum AB (publ) is overvalued by 59.7%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Swedish Orphan Valuation
Current SOBI.ST share ticker price is 323.8 SEK.
The fair value level of 130.6 SEK can be considered as an effective entry point for long-term investors to start investing in SOBI.ST stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 60% higher its fair value
Current price is 73% higher its minimum value
Current price is 41% higher its maximum value
Market price:
SOBI.ST stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
Swedish Orphan Biovitrum AB (publ) Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
31.01
2
Median P/E over 5 years
21.3
3
Minimum P/E over 5 years
14.51
4
Earning per share (last 12 months)
6.13 SEK
Maximum value
1
x
4
=
190.15 SEK
Fair value
2
x
4
=
130.6 SEK
Minimum value
3
x
4
=
88.97 SEK
Swedish Orphan Biovitrum AB (publ) price metrics
16.5
Annual return (geometric mean)
36.8
Risk (standard deviation) of returns
β
1.0
Beta (volatility compared to market)